264 is the total number of securities Camber Capital Management LP has owned. The longest Camber Capital Management LP has owned a single stock is 34 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| TEVA | TEVA PHARMACEUTICALS I... | 17 | 1 | 0.76% | 4.54% | 9.67% | Q2 2013 | Q3 2023 | 34 |
| BKD | BROOKDALE SR LIVING INC | 32 | 32 | 1.63% | 3.04% | 4.98% | Q4 2015 | Q3 2023 | 32 |
| PRGO | PERRIGO CO PLC | 23 | 1 | 1.54% | 3.84% | 7.12% | Q2 2015 | Q3 2023 | 29 |
| THC | TENET HEALTHCARE CORP | 13 | 3 | 1.29% | 4.38% | 8.48% | Q4 2013 | Q3 2023 | 28 |
| NKTR | NEKTAR THERAPEUTICS | 28 | 28 | 0.78% | 3.57% | 9.79% | Q2 2015 | Q1 2022 | 28 |
| UHS | UNIVERSAL HLTH SVCS INC | 24 | 1 | 1.72% | 5.63% | 9.89% | Q2 2013 | Q3 2023 | 25 |
| MYGN | MYRIAD GENETICS INC | 17 | 7 | 1.39% | 3.13% | 5.01% | Q4 2016 | Q3 2023 | 24 |
| SRPT | SAREPTA THERAPEUTICS INC | 9 | 1 | 0.82% | 3.14% | 6.02% | Q3 2013 | Q3 2023 | 23 |
| MYL | MYLAN NV | 21 | 21 | 2.53% | 6.62% | 10.12% | Q3 2015 | Q3 2020 | 21 |
| AMAG | AMAG PHARMACEUTICALS INC | 14 | 3 | 0.66% | 1.98% | 3.97% | Q3 2014 | Q3 2020 | 21 |
| HCA | HCA HOLDINGS INC | 6 | 1 | 1.48% | 4.25% | 5.95% | Q3 2013 | Q3 2021 | 20 |
| OSUR | ORASURE TECHNOLOGIES INC | 13 | 6 | 0.20% | 0.89% | 1.76% | Q1 2015 | Q3 2023 | 19 |
| SPY | SPDR S&P 500 ETF Trust | 4 | 1 | 6.59% | 15.78% | 28.68% | Q2 2013 | Q1 2021 | 18 |
| GHDX | GENOMIC HEALTH INC | 18 | 18 | 1.55% | 3.96% | 5.59% | Q1 2014 | Q2 2018 | 18 |
| PBYI | PUMA BIOTECHNOLOGY INC | 15 | 1 | 0.21% | 0.79% | 1.47% | Q1 2017 | Q3 2023 | 18 |
| SEM | SELECT MEDICAL HOLDING... | 10 | 7 | 0.87% | 3.45% | 4.20% | Q1 2015 | Q3 2023 | 17 |
| BIIB | BIOGEN INC | 5 | 1 | 0.65% | 3.24% | 6.92% | Q1 2016 | Q3 2022 | 17 |
| PTCT | PTC THERAPEUTICS INC | 9 | 2 | 0.34% | 1.88% | 4.26% | Q3 2014 | Q3 2023 | 17 |
| GSK | GLAXOSMITHKLINE PLC | 9 | 1 | 0.89% | 3.49% | 7.00% | Q3 2014 | Q1 2022 | 16 |
| ALKS | ALKERMES PLC | 11 | 1 | 0.20% | 3.30% | 8.05% | Q2 2016 | Q4 2021 | 16 |
| BIOL | BIOLASE INC | 12 | 4 | 0.20% | 0.48% | 0.97% | Q3 2013 | Q3 2017 | 16 |
| MDCO | MEDICINES COMPANY | 8 | 7 | 1.82% | 3.72% | 8.13% | Q4 2014 | Q2 2019 | 15 |
| OFIX | ORTHOFIX INTL N V | 15 | 15 | 0.28% | 3.01% | 4.34% | Q2 2014 | Q4 2017 | 15 |
| UAM | UNIVERSAL AMERN CORP NEW | 15 | 15 | 0.48% | 2.40% | 3.99% | Q2 2013 | Q4 2016 | 15 |
| NUVA | NUVASIVE INC. | 6 | 1 | 0.10% | 2.03% | 4.54% | Q2 2015 | Q1 2023 | 15 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 15 | 15 | 0.10% | 1.75% | 3.96% | Q1 2017 | Q3 2020 | 15 |
| COLL | COLLEGIUM PHARMACEUTIC... | 15 | 15 | 0.52% | 1.19% | 2.20% | Q1 2020 | Q3 2023 | 15 |
| MNTA | MOMENTA PHARMACEUTICAL... | 10 | 4 | 0.12% | 1.90% | 3.26% | Q2 2013 | Q2 2020 | 14 |
| ANGO | ANGIODYNAMICS INC. | 12 | 2 | 0.01% | 0.68% | 1.84% | Q2 2013 | Q4 2020 | 14 |
| GILD | GILEAD SCIENCES, INC. | 6 | 1 | 2.22% | 4.19% | 6.89% | Q2 2016 | Q1 2022 | 13 |
| ELGX | ENDOLOGIX INC | 13 | 13 | 0.31% | 1.43% | 2.26% | Q1 2016 | Q1 2019 | 13 |
| GNMK | GENMARK DIAGNOSTICS INC | 13 | 13 | 0.20% | 0.81% | 1.58% | Q2 2013 | Q2 2016 | 13 |
| PLX | PROTALIX BIOTHERAPEUTI... | 7 | 6 | 0.24% | 0.63% | 0.97% | Q2 2013 | Q3 2016 | 13 |
| VTRS | VIATRIS INC | 12 | 12 | 5.01% | 7.28% | 10.45% | Q4 2020 | Q3 2023 | 12 |
| AGN | ALLERGAN PLC | 9 | 3 | 4.14% | 7.01% | 9.76% | Q4 2016 | Q4 2019 | 12 |
| WBA | WALGREENS BOOTS ALLIAN... | 12 | 12 | 2.72% | 5.41% | 7.06% | Q4 2020 | Q3 2023 | 12 |
| MASI | MASIMO CORPORATION | 12 | 12 | 2.45% | 4.01% | 6.36% | Q2 2013 | Q1 2016 | 12 |
| NVTA | INVITAE CORP | 12 | 12 | 0.48% | 0.99% | 1.64% | Q1 2015 | Q4 2017 | 12 |
| BIOS | BIOSCRIP INC | 12 | 12 | 0.36% | 0.93% | 1.35% | Q1 2015 | Q4 2017 | 12 |
| CHNG | CHANGE HEALTHCARE INC | 11 | 11 | 1.82% | 5.71% | 11.48% | Q1 2020 | Q3 2022 | 11 |
| TEVA | TEVA PHARMACEUTICALS I... | 3 | 1 | 0.81% | 3.38% | 7.95% | Q2 2013 | Q4 2017 | 11 |
| CNMD | CONMED CORP COM | 8 | 1 | 1.04% | 3.28% | 5.19% | Q2 2013 | Q1 2023 | 11 |
| DGX | QUEST DIAGNOSTICS INC | 7 | 4 | 0.88% | 3.14% | 5.18% | Q2 2013 | Q1 2016 | 11 |
| IONS | IONIS PHARMACEUTICALS INC | 11 | 11 | 1.45% | 2.78% | 4.34% | Q1 2021 | Q3 2023 | 11 |
| ARIA | ARIAD PHARMACEUTICALS ... | 11 | 11 | 1.43% | 2.67% | 4.12% | Q4 2013 | Q2 2016 | 11 |
| MRTX | MIRATI THERAPEUTICS INC | 11 | 11 | 0.74% | 2.37% | 4.28% | Q1 2021 | Q3 2023 | 11 |
| ZYME | ZYMEWORKS INC | 6 | 5 | 0.45% | 1.10% | 2.67% | Q2 2018 | Q3 2022 | 11 |
| SNY | SANOFI | 10 | 10 | 3.99% | 7.25% | 11.63% | Q2 2021 | Q3 2023 | 10 |
| ALXN | ALEXION PHARMACEUTICAL... | 9 | 1 | 1.18% | 5.18% | 8.99% | Q2 2017 | Q4 2020 | 10 |
| ZBH | ZIMMER BIOMET HOLDINGS... | 9 | 1 | 3.27% | 5.02% | 6.84% | Q1 2021 | Q3 2023 | 10 |
| SQNM | SEQUENOM INC COM | 10 | 10 | 0.56% | 1.67% | 2.54% | Q1 2014 | Q2 2016 | 10 |
| RDUS | RADIUS HEALTH INC | 6 | 1 | 0.08% | 1.01% | 2.81% | Q2 2017 | Q1 2022 | 10 |
| CCRN | CROSS CTRY HEALTHCASE INC | 10 | 10 | 0.20% | 1.00% | 1.74% | Q2 2013 | Q3 2015 | 10 |
| AVRO | AVROBIO INC | 10 | 10 | 0.22% | 0.94% | 1.53% | Q3 2019 | Q4 2021 | 10 |
| GILD | GILEAD SCIENCES, INC. | 6 | 1 | 2.32% | 3.80% | 6.89% | Q1 2016 | Q3 2021 | 9 |
| CSII | CARDIOVASCULAR SYSTEMS... | 4 | 2 | 0.55% | 1.90% | 3.64% | Q2 2016 | Q4 2022 | 9 |
| BLUE | BLUEBIRD BIO INC | 5 | 4 | 0.38% | 1.55% | 4.45% | Q2 2013 | Q1 2021 | 9 |
| STRO | SUTRO BIOPHARMA INC | 9 | 9 | 0.26% | 0.32% | 0.38% | Q3 2018 | Q3 2020 | 9 |
| GBT | GLOBAL BLOOD THERAPEUT... | 6 | 1 | 0.14% | 2.98% | 4.75% | Q4 2017 | Q3 2020 | 8 |
| AMRN | AMARIN CORP PLC | 8 | 8 | 0.78% | 1.38% | 2.00% | Q4 2013 | Q3 2015 | 8 |
| ARNA | ARENA PHARMACEUTICALS INC | 5 | 3 | 0.25% | 1.11% | 2.37% | Q1 2015 | Q2 2017 | 8 |
| GKOS | GLAUKOS CORP | 7 | 1 | 0.12% | 0.56% | 1.60% | Q2 2020 | Q2 2023 | 8 |
| INGN | INOGEN INC | 8 | 8 | 0.21% | 0.49% | 0.88% | Q4 2021 | Q3 2023 | 8 |
| PROTALIX BIOTHERAPEUTI... | 7 | 1 | 0.24% | 0.37% | 0.53% | Q4 2014 | Q4 2016 | 8 | |
| SGRY | SURGERY PARTNERS INC | 8 | 8 | 0.06% | 0.08% | 0.11% | Q4 2017 | Q3 2019 | 8 |
| MYL | MYLAN INC | 7 | 7 | 0.96% | 4.74% | 7.60% | Q2 2013 | Q4 2014 | 7 |
| 5100PS | VOLCANO CORPORATION | 7 | 7 | 3.03% | 4.15% | 5.05% | Q2 2013 | Q4 2014 | 7 |
| LH | LABORATORY CORP AMER H... | 5 | 2 | 2.40% | 3.17% | 3.72% | Q1 2014 | Q4 2015 | 7 |
| IRWD | IRONWOOD PHARMACEUTICA... | 7 | 7 | 1.20% | 2.83% | 3.84% | Q2 2020 | Q4 2021 | 7 |
| BMRN | BIOMARIN PHARMACEUTICA... | 5 | 1 | 0.88% | 2.77% | 5.39% | Q3 2020 | Q3 2023 | 7 |
| ENDP | ENDO INT PLC | 5 | 2 | 0.73% | 2.40% | 3.80% | Q2 2016 | Q2 2018 | 7 |
| CLVS | CLOVIS ONCOLOGY INC | 7 | 7 | 1.04% | 1.91% | 2.39% | Q3 2017 | Q1 2019 | 7 |
| NVAX | NOVAVAX INC | 7 | 7 | 0.68% | 1.24% | 1.86% | Q2 2013 | Q4 2014 | 7 |
| ZIMVIE INC | 7 | 7 | 0.72% | 1.08% | 1.65% | Q1 2022 | Q3 2023 | 7 | |
| ELOS | SYNERON MEDICAL LTD | 7 | 7 | 0.64% | 0.90% | 1.25% | Q4 2015 | Q2 2017 | 7 |
| EXEL | EXELIXIS INC | 7 | 7 | 0.22% | 0.75% | 1.49% | Q1 2022 | Q3 2023 | 7 |
| CATB | CATABASIS PHARMACEUTIC... | 7 | 7 | 0.18% | 0.42% | 0.77% | Q2 2015 | Q4 2016 | 7 |
| CRDC | CARDICA INC | 7 | 7 | 0.08% | 0.40% | 0.84% | Q2 2014 | Q4 2015 | 7 |
| TRGT | TARGACEPT INC | 7 | 7 | 0.07% | 0.34% | 0.58% | Q4 2013 | Q2 2015 | 7 |
| TSRO | TESARO INC | 6 | 6 | 3.27% | 5.26% | 9.86% | Q3 2017 | Q4 2018 | 6 |
| MRK | MERCK & CO. INC NEW | 5 | 1 | 2.64% | 4.24% | 6.58% | Q4 2013 | Q1 2022 | 6 |
| ASND | ASCENDIS PHARMA A S | 6 | 6 | 2.52% | 3.43% | 4.69% | Q1 2019 | Q2 2020 | 6 |
| EVHC | ENVISION HEALTHCARE CORP | 6 | 6 | 1.07% | 3.40% | 5.38% | Q2 2017 | Q3 2018 | 6 |
| LIVN | LIVANOVA PLC | 6 | 6 | 2.38% | 3.19% | 4.60% | Q4 2015 | Q1 2017 | 6 |
| KERX | KERYX BIOPHARMACEUTICA... | 6 | 6 | 0.34% | 2.52% | 4.52% | Q1 2014 | Q2 2015 | 6 |
| INCY | INCYTE CORP | 4 | 1 | 1.39% | 2.43% | 3.96% | Q1 2020 | Q3 2022 | 6 |
| XRAY | DENTSPLY SIRONA INC | 6 | 6 | 1.23% | 1.92% | 2.30% | Q2 2022 | Q3 2023 | 6 |
| RETA | REATA PHARMACEUTICALS INC | 3 | 3 | 0.38% | 1.64% | 2.22% | Q1 2021 | Q3 2022 | 6 |
| QTRX | QUANTERIX CORP | 6 | 6 | 0.80% | 1.38% | 2.52% | Q2 2022 | Q3 2023 | 6 |
| WMGI | WRIGHT MEDICAL GROUP NV | 3 | 1 | 0.62% | 1.16% | 2.08% | Q1 2016 | Q3 2019 | 6 |
| TBIO | TRANSLATE BIO INC | 4 | 2 | 0.62% | 0.90% | 1.30% | Q3 2019 | Q2 2021 | 6 |
| INNOCOLL AG | 6 | 6 | 0.27% | 0.67% | 1.21% | Q2 2015 | Q3 2016 | 6 | |
| GLYC | GLYCOMIMETICS INC | 6 | 6 | 0.29% | 0.59% | 0.94% | Q3 2019 | Q4 2020 | 6 |
| EPRSQ | EPIRUS PHARMACEUTICALS IN | 6 | 6 | 0.04% | 0.55% | 1.18% | Q1 2015 | Q2 2016 | 6 |
| CANO | CANO HEALTH INC | 6 | 6 | 0.03% | 0.40% | 1.33% | Q2 2022 | Q3 2023 | 6 |
| TARGACEPTS INC | 6 | 6 | 0.07% | 0.09% | 0.11% | Q4 2015 | Q1 2017 | 6 | |
| BIOL | BIOLASE INC | 4 | 1 | 0.00% | 0.00% | 0.01% | Q4 2014 | Q3 2017 | 6 |
| V107SC | WELLPOINT INC | 5 | 5 | 4.94% | 6.38% | 7.45% | Q2 2013 | Q2 2014 | 5 |
| ESRX | EXPRESS SCRIPTS HLDG CO | 5 | 5 | 3.94% | 4.33% | 4.65% | Q3 2014 | Q3 2015 | 5 |
| GSK PLC | 5 | 5 | 2.25% | 3.99% | 5.03% | Q3 2022 | Q3 2023 | 5 | |
| DVA | DAVITA INC | 5 | 5 | 0.41% | 3.61% | 5.24% | Q4 2018 | Q4 2019 | 5 |
| HOLX | HOLOGIC INC | 4 | 1 | 1.50% | 3.16% | 4.87% | Q2 2013 | Q2 2021 | 5 |
| VRTX | VERTEX PHARMACEUTICALS... | 3 | 1 | 2.20% | 3.11% | 4.22% | Q3 2014 | Q4 2021 | 5 |
| CYH | COMMUNITY HEALTH SYS I... | 3 | 2 | 1.73% | 2.85% | 4.13% | Q4 2013 | Q3 2016 | 5 |
| MNKKQ | MALLINCKRODT PUB LTD CO | 3 | 1 | 0.12% | 2.56% | 4.61% | Q3 2013 | Q2 2018 | 5 |
| THC | TENET HEALTHCARE CORP THC | 5 | 5 | 1.50% | 2.21% | 2.94% | Q3 2015 | Q3 2016 | 5 |
| THOR | SYNTHORX INC | 5 | 5 | 1.17% | 1.95% | 3.56% | Q4 2018 | Q4 2019 | 5 |
| DRRX | DURECT CORP COM | 5 | 5 | 0.35% | 0.70% | 1.00% | Q2 2015 | Q2 2016 | 5 |
| EGRX | EAGLE PHARMACEUTICALS INC | 4 | 1 | 0.21% | 0.62% | 0.86% | Q4 2014 | Q1 2019 | 5 |
| PTON | PELOTON INTERACTIVE INC | 5 | 5 | 0.26% | 0.59% | 0.75% | Q3 2022 | Q3 2023 | 5 |
| AZN | ASTRAZENECA PLC | 3 | 1 | 2.72% | 4.84% | 6.82% | Q3 2013 | Q4 2015 | 4 |
| MRK | MERCK & CO INC | 3 | 1 | 3.96% | 4.77% | 5.27% | Q2 2021 | Q3 2022 | 4 |
| ABBV | ABBVIE INC | 1 | 1 | 1.99% | 3.40% | 5.46% | Q1 2015 | Q1 2020 | 4 |
| HUM | HUMANA INC | 4 | 4 | 1.77% | 3.20% | 3.91% | Q2 2013 | Q1 2014 | 4 |
| BMY | BRISTOL MYERS SQUIBB CO | 3 | 1 | 2.11% | 3.15% | 4.00% | Q1 2018 | Q3 2019 | 4 |
| BIVV | BIOVERATIV INC | 4 | 4 | 2.43% | 3.09% | 3.62% | Q1 2017 | Q4 2017 | 4 |
| MDT | MEDTRONIC PLC | 2 | 1 | 1.24% | 2.21% | 3.87% | Q1 2022 | Q3 2023 | 4 |
| MYL | MYLAN N V | 3 | 1 | 1.30% | 2.18% | 3.12% | Q4 2018 | Q4 2019 | 4 |
| BRKR | BRUKER CORP | 4 | 4 | 0.80% | 1.95% | 2.64% | Q2 2014 | Q1 2015 | 4 |
| KND | KINDRED HEALTHCARE INC | 4 | 4 | 1.48% | 1.84% | 2.55% | Q4 2014 | Q3 2015 | 4 |
| VRX | VALEANT PHARMACEUTICAL... | 3 | 1 | 1.17% | 1.81% | 3.08% | Q1 2016 | Q1 2018 | 4 |
| ABT | ABBOTT LABS | 2 | 1 | 1.03% | 1.66% | 2.00% | Q1 2014 | Q1 2017 | 4 |
| ALGN | ALIGN TECHNOLOGY INC | 4 | 4 | 0.51% | 1.38% | 2.71% | Q2 2022 | Q1 2023 | 4 |
| KTWO | K2M GROUP HLDGS INC | 4 | 4 | 0.75% | 1.23% | 1.73% | Q4 2017 | Q3 2018 | 4 |
| SKIN | THE BEAUTY HEALTH COMPANY | 3 | 1 | 0.19% | 0.98% | 2.26% | Q2 2021 | Q3 2023 | 4 |
| REPL | REPLIMUNE GROUP INC | 4 | 4 | 0.68% | 0.98% | 1.17% | Q4 2022 | Q3 2023 | 4 |
| GERN | GERON CORP | 4 | 4 | 0.63% | 0.77% | 1.05% | Q4 2013 | Q3 2014 | 4 |
| DRNA | DICERNA PHARMACEUTICAL... | 2 | 2 | 0.41% | 0.45% | 0.50% | Q4 2017 | Q4 2020 | 4 |
| INNV | INNOVAGE HLDG CORP | 4 | 4 | 0.06% | 0.43% | 0.90% | Q1 2021 | Q4 2021 | 4 |
| BROOKDALE SR LIVING INC | 4 | 4 | 0.36% | 0.43% | 0.50% | Q4 2022 | Q3 2023 | 4 | |
| NSTG | NANOSTRING TECHNOLOGIE... | 4 | 4 | 0.39% | 0.43% | 0.47% | Q2 2022 | Q1 2023 | 4 |
| SOLID BIOSCIENCES INC | 4 | 4 | 0.12% | 0.21% | 0.26% | Q4 2022 | Q3 2023 | 4 | |
| DXTRQ | DEXTERA SURGICAL INC. | 4 | 4 | 0.04% | 0.06% | 0.07% | Q2 2016 | Q1 2017 | 4 |
| BIOLASE INC | 4 | 4 | 0.00% | 0.00% | 0.00% | Q4 2015 | Q3 2016 | 4 | |
| AGN | ALLERGAN PLC | 2 | 1 | 3.90% | 4.89% | 6.34% | Q4 2018 | Q3 2019 | 3 |
| PFE | PFIZER INC | 1 | 1 | 2.64% | 4.73% | 8.20% | Q2 2021 | Q3 2023 | 3 |
| CYBX | CYBERONICS INC | 3 | 3 | 3.48% | 4.24% | 5.21% | Q1 2015 | Q3 2015 | 3 |
| BAX | BAXTER INTL INC | 3 | 3 | 3.73% | 3.98% | 4.45% | Q1 2023 | Q3 2023 | 3 |
| BMY | BRISTOL-MYERS SQUIBB CO | 1 | 1 | 2.47% | 3.69% | 4.35% | Q2 2018 | Q4 2020 | 3 |
| CAH | CARDINAL HEALTH INC | 2 | 1 | 2.40% | 3.38% | 4.10% | Q2 2013 | Q2 2021 | 3 |
| VTR | VENTAS INC | 2 | 1 | 1.65% | 3.02% | 5.20% | Q4 2019 | Q1 2021 | 3 |
| BHC | BAUSCH HEALTH COS INC | 2 | 1 | 0.88% | 2.56% | 3.69% | Q4 2018 | Q4 2020 | 3 |
| UNH | UNITEDHEALTH GROUP INC... | 2 | 1 | 1.35% | 2.53% | 4.32% | Q2 2013 | Q1 2014 | 3 |
| ALNY | ALYNYLAM PHARMACEUTICA... | 1 | 1 | 1.72% | 2.33% | 3.19% | Q2 2013 | Q4 2018 | 3 |
| AZN | BIOLASE INC | 2 | 1 | 0.00% | 2.27% | 4.04% | Q3 2015 | Q3 2021 | 3 |
| LDRH | LDR HOLDING CORP | 3 | 3 | 0.87% | 2.23% | 3.36% | Q4 2015 | Q2 2016 | 3 |
| CHRS | COHERUS BIOSCIENCES INC | 3 | 3 | 1.34% | 1.91% | 2.25% | Q2 2020 | Q4 2020 | 3 |
| WW | WEIGHT WATCHERS INTL I... | 3 | 3 | 1.12% | 1.87% | 2.58% | Q2 2014 | Q4 2014 | 3 |
| GMED | GLOBUS MED INC | 3 | 3 | 0.53% | 1.76% | 2.82% | Q1 2023 | Q3 2023 | 3 |
| SNY | SANOFI | 2 | 1 | 1.16% | 1.74% | 2.58% | Q3 2021 | Q3 2022 | 3 |
| ARWR | ARROWHEAD RESH CORP | 3 | 3 | 0.64% | 1.19% | 1.49% | Q2 2013 | Q4 2013 | 3 |
| DSCI | DERMA SCIENCES INC | 3 | 3 | 0.47% | 1.00% | 1.30% | Q2 2013 | Q4 2013 | 3 |
| HLF | HERBALIFE NUTRITION LTD | 3 | 3 | 0.41% | 0.97% | 1.31% | Q1 2023 | Q3 2023 | 3 |
| BRLI | BIO-REFERENCE LABS INC | 3 | 3 | 0.02% | 0.85% | 1.43% | Q2 2014 | Q4 2014 | 3 |
| TRNX | TORNIER N V | 3 | 3 | 0.41% | 0.77% | 1.02% | Q4 2013 | Q2 2014 | 3 |
| CNC | CENTENE CORPORATION | 2 | 1 | 0.59% | 0.75% | 0.88% | Q4 2016 | Q2 2023 | 3 |
| CVAC | CUREVAC N V | 3 | 3 | 0.27% | 0.39% | 0.50% | Q1 2023 | Q3 2023 | 3 |
| INO | INOVIO PHARMACEUTICALS... | 3 | 3 | 0.15% | 0.18% | 0.23% | Q3 2014 | Q1 2015 | 3 |
| UNIS | UNILIFE CORP NEW | 3 | 3 | 0.09% | 0.14% | 0.23% | Q3 2015 | Q1 2016 | 3 |
| SDC | SMILEDIRECTCLUB INC | 3 | 3 | 0.03% | 0.06% | 0.09% | Q4 2021 | Q2 2022 | 3 |
| SHPG | SHIRE PLC | 2 | 2 | 4.22% | 6.14% | 8.07% | Q1 2018 | Q2 2018 | 2 |
| MCK | MCKESSON CORP | 2 | 2 | 4.26% | 4.42% | 4.59% | Q3 2018 | Q4 2018 | 2 |
| NVS | NOVARTIS AG | 2 | 2 | 3.01% | 4.02% | 5.04% | Q3 2021 | Q4 2021 | 2 |
| GSK | GLAXOSMITHKLINE PLC | 2 | 2 | 2.84% | 3.58% | 4.32% | Q3 2014 | Q4 2014 | 2 |
| CI | CIGNA CORPORATION | 1 | 1 | 3.09% | 3.20% | 3.31% | Q2 2015 | Q2 2016 | 2 |
| MJN | MEAD JOHNSON NUTRITION CO | 2 | 2 | 2.55% | 3.08% | 3.62% | Q3 2015 | Q4 2015 | 2 |
| MAKO | MAKO SURGICAL CORP | 2 | 2 | 2.23% | 2.97% | 3.71% | Q2 2013 | Q3 2013 | 2 |
| ACHN | ACHILLION PHARMACEUTIC... | 2 | 2 | 2.88% | 2.96% | 3.05% | Q2 2014 | Q3 2014 | 2 |
| HAE | HAEMONETICS CORP | 2 | 2 | 2.31% | 2.69% | 3.07% | Q1 2014 | Q2 2014 | 2 |
| A | AGILENT TECHNOLOGIES, INC | 2 | 2 | 2.52% | 2.60% | 2.69% | Q3 2013 | Q4 2013 | 2 |
| GIVN | GIVEN IMAGING | 2 | 2 | 2.16% | 2.59% | 3.02% | Q2 2013 | Q3 2013 | 2 |
| XLV | SELECT SECTOR SPDR TR | 1 | 1 | 0.08% | 2.57% | 5.06% | Q2 2015 | Q4 2015 | 2 |
| HRC | HILL ROM HLDGS INC | 2 | 2 | 1.81% | 2.12% | 2.43% | Q1 2014 | Q2 2014 | 2 |
| T107PS | WRIGHT MED GROUP INC | 2 | 2 | 1.94% | 2.12% | 2.29% | Q2 2013 | Q3 2013 | 2 |
| SGEN | SEAGEN INC | 2 | 2 | 1.05% | 1.63% | 2.20% | Q3 2022 | Q4 2022 | 2 |
| BSX | BOSTON SCIENTIFIC CORP | 1 | 1 | 0.95% | 1.58% | 2.20% | Q2 2013 | Q4 2014 | 2 |
| UTHR | UNITED THERAPEUTICS CO... | 2 | 2 | 1.34% | 1.51% | 1.68% | Q2 2019 | Q3 2019 | 2 |
| PACIFIC BIOSCIENCES CA... | 2 | 2 | 0.61% | 1.46% | 2.30% | Q2 2020 | Q3 2020 | 2 | |
| ICUI | ICU MED INC | 2 | 2 | 1.11% | 1.39% | 1.67% | Q2 2014 | Q3 2014 | 2 |
| ALR | ALERE INC | 1 | 1 | 1.26% | 1.26% | 1.26% | Q2 2013 | Q4 2014 | 2 |
| TRVN | TREVENA INC | 2 | 2 | 1.14% | 1.24% | 1.34% | Q4 2014 | Q1 2015 | 2 |
| FURX | FURIEX PHARMACEUTICALS... | 2 | 2 | 1.02% | 1.21% | 1.39% | Q1 2014 | Q2 2014 | 2 |
| WCG | WELLCARE HEALTH PLANS INC | 1 | 1 | 0.95% | 1.14% | 1.33% | Q2 2013 | Q3 2014 | 2 |
| CYCN | CYCLERION THERAPEUTICS... | 2 | 2 | 0.83% | 1.13% | 1.42% | Q2 2019 | Q3 2019 | 2 |
| SAGE | SAGE THERAPEUTICS INC | 1 | 1 | 0.92% | 1.08% | 1.25% | Q2 2020 | Q4 2022 | 2 |
| RVNC | REVANCE THERAPEUTICS INC | 2 | 2 | 0.74% | 1.07% | 1.40% | Q1 2014 | Q2 2014 | 2 |
| ITMN | INTERMUNE INC | 2 | 2 | 0.81% | 1.07% | 1.34% | Q2 2013 | Q3 2013 | 2 |
| MGLN | MAGELLAN HEALTH SVCS INC | 2 | 2 | 1.01% | 1.05% | 1.10% | Q2 2013 | Q3 2013 | 2 |
| QUIDELORTHO CORP | 1 | 1 | 0.78% | 1.05% | 1.31% | Q3 2022 | Q3 2023 | 2 | |
| IMVT | IMMUNOVANT INC | 2 | 2 | 0.81% | 0.96% | 1.12% | Q2 2020 | Q3 2020 | 2 |
| QGEN | QIAGEN NV | 1 | 1 | 0.53% | 0.91% | 1.28% | Q4 2022 | Q3 2023 | 2 |
| EVH | EVOLENT HEALTH INC | 2 | 2 | 0.22% | 0.77% | 1.33% | Q1 2022 | Q2 2022 | 2 |
| NXTM | NXSTAGE MEDICAL INC | 2 | 2 | 0.72% | 0.77% | 0.82% | Q4 2013 | Q1 2014 | 2 |
| VCYT | VERACYTE INC | 2 | 2 | 0.37% | 0.65% | 0.93% | Q2 2015 | Q3 2015 | 2 |
| XNPT | XENOPORT INC | 2 | 2 | 0.48% | 0.49% | 0.51% | Q3 2013 | Q4 2013 | 2 |
| TBPH | THERAVANCE BIOPHARMA INC | 2 | 2 | 0.19% | 0.38% | 0.57% | Q3 2021 | Q4 2021 | 2 |
| PRTA | PROTHENA CORP PLC | 2 | 2 | 0.23% | 0.34% | 0.45% | Q4 2017 | Q1 2018 | 2 |
| PACB | PACIFIC BIOSCIENCES CA... | 1 | 1 | 0.08% | 0.27% | 0.46% | Q1 2020 | Q2 2022 | 2 |
| ANTH | ANTHERA PHARMACEUTICAL... | 2 | 2 | 0.00% | 0.00% | 0.00% | Q2 2013 | Q3 2013 | 2 |
| QQQ | INVESCO QQQ TR | 1 | 1 | 9.87% | 9.87% | 9.87% | Q1 2023 | Q1 2023 | 1 |
| SYK | STRYKER CORP | 1 | 1 | 6.24% | 6.24% | 6.24% | Q4 2016 | Q4 2016 | 1 |
| V107SC | WELLPOINT INC | 1 | 1 | 5.47% | 5.47% | 5.47% | Q2 2013 | Q2 2013 | 1 |
| CELG | CELGENE CORP | 1 | 1 | 4.56% | 4.56% | 4.56% | Q4 2018 | Q4 2018 | 1 |
| VHS | VANGUARD HEALTH SYS INC | 1 | 1 | 4.27% | 4.27% | 4.27% | Q2 2013 | Q2 2013 | 1 |
| STJ | ST. JUDE MEDICAL, INC. | 1 | 1 | 4.03% | 4.03% | 4.03% | Q1 2016 | Q1 2016 | 1 |
| ABBV | ABBVIE INC | 1 | 1 | 3.76% | 3.76% | 3.76% | Q4 2020 | Q4 2020 | 1 |
| REGENERON PHARMACEUTIC... | 1 | 1 | 3.51% | 3.51% | 3.51% | Q4 2015 | Q4 2015 | 1 | |
| JNJ | JOHNSON & JOHNSON | 1 | 1 | 3.32% | 3.32% | 3.32% | Q2 2015 | Q2 2015 | 1 |
| CELG | CELGENE CORP | 1 | 1 | 3.06% | 3.06% | 3.06% | Q2 2018 | Q2 2018 | 1 |
| CRL | CHARLES RIV LABS INTL INC | 1 | 1 | 3.01% | 3.01% | 3.01% | Q3 2022 | Q3 2022 | 1 |
| ACT | ACTAVIS INC | 1 | 1 | 2.60% | 2.60% | 2.60% | Q2 2013 | Q2 2013 | 1 |
| EXAS | EXACT SCIENCES CORP | 1 | 1 | 2.57% | 2.57% | 2.57% | Q4 2017 | Q4 2017 | 1 |
| CARDIOVASCULAR SYS INC... | 1 | 1 | 2.52% | 2.52% | 2.52% | Q4 2015 | Q4 2015 | 1 | |
| CARDIOVASCULAR SYSTEMS... | 1 | 1 | 2.49% | 2.49% | 2.49% | Q1 2016 | Q1 2016 | 1 | |
| ALKS | ALKERMES INC | 1 | 1 | 2.40% | 2.40% | 2.40% | Q1 2016 | Q1 2016 | 1 |
| ABC | AMERISOURCEBERGEN CORP | 1 | 1 | 2.40% | 2.40% | 2.40% | Q2 2016 | Q2 2016 | 1 |
| AMGEN INC | 1 | 1 | 2.28% | 2.28% | 2.28% | Q4 2016 | Q4 2016 | 1 | |
| CI | CIGNA CORP NEW | 1 | 1 | 2.23% | 2.23% | 2.23% | Q3 2020 | Q3 2020 | 1 |
| BMY | BRISTOL MYERS SQUIBB CO | 1 | 1 | 2.22% | 2.22% | 2.22% | Q4 2015 | Q4 2015 | 1 |
| MDVN | MEDIVATION INC. | 1 | 1 | 2.22% | 2.22% | 2.22% | Q1 2016 | Q1 2016 | 1 |
| CAH | CARDINAL HEALTH INC | 1 | 1 | 2.12% | 2.12% | 2.12% | Q4 2018 | Q4 2018 | 1 |
| PFNX | PFIZER INC | 1 | 1 | 2.07% | 2.07% | 2.07% | Q4 2014 | Q4 2014 | 1 |
| EW | EDWARDS LIFESCIENCES CORP | 1 | 1 | 2.03% | 2.03% | 2.03% | Q4 2013 | Q4 2013 | 1 |
| WELL | WELLTOWER INC | 1 | 1 | 1.99% | 1.99% | 1.99% | Q1 2021 | Q1 2021 | 1 |
| VTRS | VIATRIS INC | 1 | 1 | 1.91% | 1.91% | 1.91% | Q4 2022 | Q4 2022 | 1 |
| NVO | NOVO-NORDISK A S | 1 | 1 | 1.90% | 1.90% | 1.90% | Q3 2019 | Q3 2019 | 1 |
| XRAY | DENTSPLY INTL INC NEW | 1 | 1 | 1.76% | 1.76% | 1.76% | Q2 2015 | Q2 2015 | 1 |
| ATHN | ATHENAHEALTH INC | 1 | 1 | 1.64% | 1.64% | 1.64% | Q4 2016 | Q4 2016 | 1 |
| HMSY | HMS HLDGS CORP | 1 | 1 | 1.64% | 1.64% | 1.64% | Q3 2015 | Q3 2015 | 1 |
| WBA | WALGREENS BOOTS ALLIAN... | 1 | 1 | 1.40% | 1.40% | 1.40% | Q4 2020 | Q4 2020 | 1 |
| OTIC | OTONOMY INC | 1 | 1 | 1.29% | 1.29% | 1.29% | Q3 2014 | Q3 2014 | 1 |
| ARENA PHARMACEUTICALS INC | 1 | 1 | 1.29% | 1.29% | 1.29% | Q4 2015 | Q4 2015 | 1 | |
| ARENA PHARMACEUTICALS INC | 1 | 1 | 1.21% | 1.21% | 1.21% | Q1 2016 | Q1 2016 | 1 | |
| AXGT | AXOVANT SCIENCES LTD | 1 | 1 | 1.13% | 1.13% | 1.13% | Q2 2017 | Q2 2017 | 1 |
| MD | MEDNAX INC | 1 | 1 | 1.12% | 1.12% | 1.12% | Q4 2019 | Q4 2019 | 1 |
| BEAT | CARDIONET INC | 1 | 1 | 1.09% | 1.09% | 1.09% | Q2 2013 | Q2 2013 | 1 |
| IDIX | IDENIX PHARMACEUTICALS... | 1 | 1 | 1.02% | 1.02% | 1.02% | Q2 2013 | Q2 2013 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES... | 1 | 1 | 1.02% | 1.02% | 1.02% | Q1 2022 | Q1 2022 | 1 |
| AMED | AMEDISYS INC | 1 | 1 | 0.96% | 0.96% | 0.96% | Q2 2013 | Q2 2013 | 1 |
| ARNA | ARENA PHARMACEUTICALS INC | 1 | 1 | 0.92% | 0.92% | 0.92% | Q4 2018 | Q4 2018 | 1 |
| IRTC | IRHYTHM TECHNOLOGIES INC | 1 | 1 | 0.86% | 0.86% | 0.86% | Q3 2021 | Q3 2021 | 1 |
| MDRX | ALLSCRIPTS HEALTHCASE ... | 1 | 1 | 0.85% | 0.85% | 0.85% | Q1 2015 | Q1 2015 | 1 |
| AVXS | AVEXIS INC | 1 | 1 | 0.84% | 0.84% | 0.84% | Q2 2017 | Q2 2017 | 1 |
| RMTI | ROCKWELL MED INC | 1 | 1 | 0.74% | 0.74% | 0.74% | Q2 2013 | Q2 2013 | 1 |
| RAD | RITE AID CORP | 1 | 1 | 0.72% | 0.72% | 0.72% | Q2 2017 | Q2 2017 | 1 |
| AFFX | AFFYMETRIX INC | 1 | 1 | 0.66% | 0.66% | 0.66% | Q4 2014 | Q4 2014 | 1 |
| PODD | INSULET CORP | 1 | 1 | 0.54% | 0.54% | 0.54% | Q3 2015 | Q3 2015 | 1 |
| EXAS | EXACT SCIENCES CORP | 1 | 1 | 0.51% | 0.51% | 0.51% | Q2 2022 | Q2 2022 | 1 |
| CELGZ | CELGENE CORP | 1 | 1 | 0.50% | 0.50% | 0.50% | Q2 2013 | Q2 2013 | 1 |
| PLX | PROTALIX BIOTHERAPEUTI... | 1 | 1 | 0.49% | 0.49% | 0.49% | Q1 2015 | Q1 2015 | 1 |
| RPRX | REPROS THERAPEUTICS INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q2 2014 | Q2 2014 | 1 |
| BIOLASE INC | 1 | 1 | 0.41% | 0.41% | 0.41% | Q3 2016 | Q3 2016 | 1 | |
| TGTX | TG THERAPEUTICS INC | 1 | 1 | 0.40% | 0.40% | 0.40% | Q2 2019 | Q2 2019 | 1 |
| OSH | OAK STR HEALTH INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q3 2022 | Q3 2022 | 1 |
| BCYC | BICYCLE THERAPEUTICS PLC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2023 | Q3 2023 | 1 |
| PROTALIX BIOTHEAPEUTIC... | 1 | 1 | 0.25% | 0.25% | 0.25% | Q1 2015 | Q1 2015 | 1 | |
| NTUS | NATUS MEDICAL INC DEL | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2013 | Q2 2013 | 1 |
| ENTA | ENANTA PHARMACEUTICALS... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q4 2022 | Q4 2022 | 1 |
| CRDC | CARDICA INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2016 | Q1 2016 | 1 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2023 | Q2 2023 | 1 |
| CBIO | CATALYST BIOSCIENCES INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2015 | Q3 2015 | 1 |
| 2SEVENTY BIO INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2022 | Q2 2022 | 1 | |
| VIR | VIR BIOTECHNOLOGY INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2020 | Q3 2020 | 1 |
| VIRC | VIRCO MFG CO | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2020 | Q3 2020 | 1 |
Download | |||||||||
The securities at the top of the list , including TEVA PHARMACEUTICALS INDS LTD, BROOKDALE SR LIVING INC, and PERRIGO CO PLC, are the highest-conviction holdings of Camber Capital Management LP.
The conviction is calculated by counting the number of quarters a security has been reported by Camber Capital Management LP. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Camber Capital Management LP owns currently or has owned in the past.